Tumor Treg depletion by IL‐2‐Fc was most evident in our early time point monotherapy studies, especially 1 day posttreatment in our MC38/CEA short term study, with some mice reaching a >50‐fold higher IFNγ+CD8+/Treg ratio (Figure 2K). The gene discussed is IFNG; the disease is neoplasm.